[4 cases of agranulocytosis during treatments with cephalothin].
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D002512:Cephalothin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D002512:Cephalothin
A propos de 4 observations d'agranulocytose au cours de traitements par la céphalotine